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Cortical circuit alterations precede 
motor impairments in Huntington’s 
disease mice
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Jakob Maximilian Bader  2, Fabian Hosp2, Matthias Mann  2, thomas Arzberger3,4,5, 
Rüdiger Klein  1,6, sabine Liebscher6,7,8 & Irina Dudanova  1
Huntington’s disease (HD) is a devastating hereditary movement disorder, characterized by 
degeneration of neurons in the striatum and cortex. studies in human patients and mouse HD models 
suggest that disturbances of neuronal function in the neocortex play an important role in disease 
onset and progression. However, the precise nature and time course of cortical alterations in HD 
have remained elusive. Here, we use chronic in vivo two-photon calcium imaging to longitudinally 
monitor the activity of identified single neurons in layer 2/3 of the primary motor cortex in awake, 
behaving R6/2 transgenic HD mice and wildtype littermates. R6/2 mice show age-dependent changes 
in cortical network function, with an increase in activity that affects a large fraction of cells and occurs 
rather abruptly within one week, preceeding the onset of motor defects. Furthermore, quantitative 
proteomics demonstrate a pronounced downregulation of synaptic proteins in the cortex, and 
histological analyses in R6/2 mice and human HD autopsy cases reveal a reduction in perisomatic 
inhibitory synaptic contacts on layer 2/3 pyramidal cells. Taken together, our study provides a time-
resolved description of cortical network dysfunction in behaving HD mice and points to disturbed 
excitation/inhibition balance as an important pathomechanism in HD.
Huntington’s disease (HD) is an incurable hereditary neurodegenerative disorder, characterized by choreatic 
movements in combination with cognitive decline and psychiatric symptoms. HD is caused by an expansion of 
the CAG repeat in exon 1 of the Huntingtin gene1, resulting in the expression of the aggregation-prone mutant 
Huntingtin (mHTT) protein with an elongated polyglutamine (polyQ) tract. mHTT interferes with multiple cel-
lular functions, including transcription, energy metabolism, protein homeostasis and intracellular transport2,3. 
The striatum is the most vulnerable region in HD, however, prominent pathological changes are also observed 
in the neocortex4–6. Importantly, ample evidence points towards the disturbance of cortical function and impair-
ment of corticostriatal communication as crucial early events in HD7–10. Imaging studies in human HD gene 
expansion carriers demonstrate that cortical thinning and abnormalities of cortical activity contribute to the 
onset, progression and clinical variability of the disease6,11–16. In particular, primary motor cortex (M1) is among 
the regions showing the earliest changes15, and the degree of cell loss in this area correlates with the motor impair-
ments17. In addition, analyses of tissue-specific conditional mouse models revealed the requirement of mHTT in 
both the striatum and the cortex for driving the full extent of HD phenotypes18,19. Likewise, mHTT lowering in 
both regions is necessary for an efficient rescue of HD-related deficits20,21.
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Previous studies in HD mouse models uncovered multiple morphological and electrophysiological abnor-
malities of cortical pyramidal neurons (principal cells, PCs). Reduced dendritic arborizations and a decline in 
the density and stability of dendritic spines on PCs were observed in the somatosensory cortex22–24. These defects 
were paralleled by lower levels of several synaptic proteins and a decrease in excitatory synapse density, detected 
at an advanced disease stage24. Moreover, conditional mouse models demonstrated the importance of mHTT 
expression in inhibitory interneurons as well as PCs for the development of cortical pathology and behavioral 
defects19. Electrophysiological recordings in various HD mice revealed changes in both excitatory and inhibitory 
inputs onto layer 2/3 (L2/3) PCs, with a consistent reduction in the frequency of spontaneous inhibitory postsyn-
aptic currents (sIPSCs)19,25,26. Despite these insights into the cortical circuit impairments in HD, it has remained 
unclear how cortical network function is affected in vivo during the presymptomatic phase and at disease onset, 
and which molecular and circuit mechanisms underlie these functional alterations.
Here, we use chronic in vivo two-photon calcium imaging in awake, behaving HD mice to monitor the activity 
of large populations of L2/3 neurons in the M1 area at single-cell resolution. Our imaging experiments reveal an 
increase in neuronal activity that affects a large fraction of cells and precedes the onset of motor impairments. 
Proteomic analyses show a pronounced downregulation of synaptic proteins in the cortex, whereas histological 
findings in HD mouse brains and in human postmortem tissue point to a loss of inhibitory synapses on PCs, 
suggesting that excitation/inhibition dysbalance plays a role in the cortical dysfunction in HD.
Results
Chronic two-photon calcium imaging in the cortex of R6/2 mice. We investigated neuronal activity 
in R6/2 transgenic mice, which express mHTT-exon 1 with a pathological polyQ expansion under the human 
HTT promoter and are characterized by an early onset and rapid progression of the disease27–29. In spite of con-
siderable brain atrophy, no obvious cell loss has been reported in this line until the age of 12 weeks28,30,31. Overt 
neurological symptoms such as tremor, dyskinesia and balance impairment start at 9–11 weeks of age28. The exact 
age of onset of motor deficits varies between different R6/2 colonies and is dependent on the CAG repeat length, 
which can increase over generations due to genetic instability of the repeats. Several studies have described later 
onset and overall attenuation of HD-related phenotypes in animals with very high repeat numbers32,33. The CAG 
repeat length in our colony averaged 192 ± 2 repeats and was higher than in the original line (~150 repeats)28. We 
therefore characterized the motor phenotype in our colony by testing the mice on an accelerating rotarod and 
in the open field. 8 to 9-week-old R6/2 mice showed no significant deficits on the rotarod and normal locomo-
tion in the open field, whereas by the age of 12–13 weeks, they were severely impaired in both tests (WT, 7–10 
mice; R6/2, 10 mice; Two-way ANOVA with Bonferroni’s multiple comparison test; Rotarod, 8–9 weeks, p > 0.05; 
12–13 weeks, p < 0.001; Open field, 8–9 weeks, p > 0.05; 12–13 weeks, p < 0.001; Fig. 1a). We conclude that the 
onset of motor defects in our colony occurs after 9 weeks of age and is thus slightly delayed compared to other 
reports23,27, likely due to the expansion of CAG repeats and/or differences in housing conditions.
To study longitudinal changes in neuronal function before the onset of motor impairments, we chronically 
monitored calcium transients in L2/3 neurons in M1 cortex of R6/2 mice and wildtype (WT) littermates (Fig. 1b). 
Mice were injected with AAV1/2-Syn1-mRuby2-P2A-GCaMP6s34, which allows functional imaging along with 
morphological labeling of the neurons (Fig. 1c,d). Because of the rapid disease progression in this mouse line, 
we performed virus injections and cranial window implantations at the age of 3.5 weeks (Fig. 1b). Two-photon 
imaging sessions of 15 min each were started 3 weeks after the surgery and carried out at weekly intervals between 
6.5 and 9.5 weeks of age (Fig. 1b). Populations of 100–200 L2/3 neurons were imaged in awake head-restrained 
animals during voluntary locomotion in the dark on a spherical treadmill restricted to movement around one 
axis35 (Fig. 1e). Only neurons that could be unambiguously reidentified in all imaging sessions were included in 
the analysis. The fraction of reidentified cells varied between 65% and 90% per field of view (FOV) and was not 
Figure 1. Chronic two-photon calcium imaging in awake R6/2 mice. (a) Left: Latency to fall on the accelerating 
rotarod. Right: Distance traveled in the open field. ***p < 0.001. (b) Experimental design and timeline of R6/2 
phenotypes. (c) Scheme of a cranial window over the M1 cortex. (d) Coronal brain section showing AAV1/2-
mediated expression of mRuby2 (red) and GCaMP6s (green) in L2/3 neurons in M1. (e) Imaging setup. A 
mouse head-fixed under a two-photon microscope is placed on a spherical treadmill floating on pressurized 
air. Neuronal activity is monitored through a cranial window. Running behavior is registered by an IR-sensitive 
video camera and a speed sensor.
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significantly different between the genotypes (mean ± SD: WT, 79.3 ± 9.5%; R6/2, 80.6 ± 5.4%; Student’s t-test, 
p = 0.8254). The experiments ended before the animals developed overt neurological symptoms such as tremor, 
balance problems or change of posture. During the imaging sessions, mice exhibited spontaneous running behav-
ior, which was recorded by an infrared (IR)-sensitive video camera and/or by an optical mouse sensor (Fig. 1e).
Increased neuronal activity in HD mice prior to motor impairments. Calcium transients were 
observed in many L2/3 neurons, with activity remaining quite stable during the imaging period in WT mice, but 
increasing on average in R6/2 mutants (Fig. 2a). Accordingly, the distribution of calcium transient frequencies did 
not change during the imaging period in WT mice, while in R6/2 animals it was shifted towards higher frequen-
cies starting from 8.5 weeks of age (WT, 1612 neurons from 6 mice; R6/2, 2589 neurons from 5 mice; Repeated 
measures ANOVA, Genotype: F(1, 12597) = 2.01, p = 0.16; Age: F(3, 12597) = 82.91, p < 0.001; Interaction F(3, 
12597) = 101.2, p < 0.001; Fig. 2a,b). This effect was also evident when we analyzed the periods during which the 
Figure 2. Increased neuronal activity before the onset of motor defects in R6/2 mice. (a) Top: Examples of 
imaged areas in WT and R6/2 mice superimposed by activity maps. Color coding shows normalized maximum 
activity. Bottom: Calcium traces of neurons marked on the images above. (b) Cumulative distributions of 
calcium transient frequencies at the indicated time points in WT (left) and R6/2 (right) animals. Note a shift in 
the distribution towards higher frequencies occurring at 8.5 weeks in R6/2 mice. (c) Cumulative distributions 
of calcium transient frequencies during stationary epochs at the indicated time points in WT (left) and R6/2 
(right) animals. (d) Fraction of active cells at different imaging time points in WT and R6/2 mice. (e) Fraction of 
active cells under 1.5% isoflurane anesthesia at 9.5 weeks. (f) Reoccurrence rate of active cells in WT and R6/2 
mice. (g) Box plots showing activity changes of single cells between the first and later time points. (h) Example 
traces of highly active, intermediately active, rarely active and silent neurons. (i) Alluvial plots showing the 
distribution of imaged cells into four activity categories at each time point (stacked bars), as well as changes 
between the activity categories over time (stream fields) in WT (left) and R6/2 (right) animals. *p < 0.05, 
***p < 0.001.
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animal remained stationary (only experiments with a minimum of 1% stationary time were included in this anal-
ysis; WT, 1346 neurons from 6 mice; R6/2, 2589 neurons from 5 mice; Repeated measures ANOVA, Genotype: 
F(1, 11599) = 0.08, p = 0.78; Age: F(3, 11599) = 73.43, p < 0.001; Interaction F(3, 11599) = 102.66, p < 0.001; 
Fig. 2c. Of note, the effect also held true for other cutoffs of minimal stationary time), indicating that the elevated 
activity was independent of locomotion. In agreement with previous studies28,31, we did not observe a significant 
difference in cell numbers in L2/3 of M1 between R6/2 mice and WT littermates at the age of 8 weeks (3 WT and 3 
R6/2 mice; Student’s t-test, p = 0.3071; Supplementary Fig. S1), suggesting that the observed changes in network 
activity are not related to cell death.
Next, we quantified the fraction of active cells (exhibiting at least one calcium transient during an imaging session, 
see Materials and Methods) at different time points. This analysis revealed a higher fraction of active cells in R6/2 
mice from 8.5 weeks onwards (WT, 7 FOVs from 6 mice; R6/2, 10 FOVs from 5 mice; Repeated measures ANOVA, 
Genotype: F(1, 45) = 1.11, p = 0.31; Age: F(3, 45) = 3.84, p = 0.02; Interaction F(3, 45) = 3.73, p = 0.02; Fig. 2d). After 
the last awake imaging session, some of the mice were additionally imaged under isoflurane anesthesia. Consistent 
with our findings in awake animals, we observed more active cells in R6/2 mice than in WT littermates (WT, 6 FOVs 
from 3 mice; R6/2, 4 FOVs from 2 mice; Wilcoxon rank-sum test, p = 0.038; Fig. 2e). In summary, these data demon-
strate elevated neuronal activity in the cortex of HD mice before the onset of neurological and motor impairments.
Altered dynamics of single-cell activity in HD mice. We next analyzed the reoccurrence rate of active 
cells, i.e. the fraction of cells that were active at the given imaging time point and remained active in each of 
the following imaging sessions. In WT mice, the reoccurrence rates of active cells steadily declined throughout 
the imaging period. In R6/2 animals this decline was also observed, however, it slowed down from 8.5 weeks 
onwards, resulting in a higher reoccurrence rate compared to WT controls (WT, 7 FOVs from 6 mice; R6/2, 10 
FOVs from 5 mice; Repeated measures ANOVA, 6.5 to 9.5 weeks: Genotype: F(1, 45) = 2.61, p = 0.12; Age: F(3, 
45) = 130.0, p < 0.001; Interaction F(3, 45) = 3.97, p = 0.01. 7.5 to 9.5 weeks: Genotype: F(1, 30) = 8.59, p = 0.01; 
Age: F(2, 30) = 94.42, p < 0.001; Interaction F(2, 30) = 5.33, p = 0.01. 8.5 to 9.5 weeks: Genotype: F(1, 15) = 2.01, 
p = 0.18; Age: F(1, 15) = 94.42, p < 0.001; Interaction F(1, 15) = 2.01, p = 0.18; Fig. 2f).
In addition, we followed activity changes of individual neurons over time. While we observed highly dynamic 
activity profiles of single cells in both genotypes during the imaging period (Supplementary Fig. S1), there was no 
net change in the frequency of calcium transients per cell in WT animals at any time point (Fig. 2g). In contrast, 
we detected an increase in transient frequencies in the majority of cells in R6/2 mice at 8.5 weeks of age (WT, 
1612 neurons from 6 mice; R6/2, 2589 neurons from 5 mice; Wilcoxon rank-sum test, WT vs. R6/2, 6.5–7.5 
weeks, p > 0.05; 6.5–8.5 weeks, p < 0.001; 6.5–9.5 weeks, p < 0.001; Figs 2g and S1), with the median change per 
cell between 6.5 and 8.5 weeks amounting to 0.5 transients/min. These data indicate that the increase in activity 
observed in behaving R6/2 mice is a global effect, due to moderate changes in the activity of many cells, rather 
than to a small fraction of cells markedly increasing their firing.
We further examined activity levels of single neurons by subdividing them into four activity categories: silent 
(0 Ca2+ transients/min), rarely active (>0–0.5 transients/min), intermediately active (>0.5–4 transients/min), and 
highly active (>4 transients/min) (Fig. 2h). In the first two imaging sessions, the distribution of cells into these four 
categories was not significantly different between R6/2 and WT mice (Fig. 2i). However, a clear shift in the distri-
bution was observed in the R6/2 animals between 7.5 and 8.5 weeks of age (WT, 1612 neurons from 6 mice; R6/2, 
2589 neurons from 5 mice; Pearson’s Chi-square test, R6/2 vs. WT at 6.5 weeks, p = 0.5347; at 7.5 weeks, p = 0.901; 
at 8.5 weeks, p = 0.0495; at 9.5 weeks, p = 0.0198), with an increase in the fraction of intermediately active cells, and 
a reduction in the fraction of silent cells, while the rarely active and the highly active fractions did not change signif-
icantly (Fig. 2i). The increase in the intermediately active category in the R6/2 mice at 8.5 weeks was to a large extent 
due to cells that were classified as silent at 7.5 weeks (26% of silent cells became intermediately active in WT vs. 54% 
in R6/2; Exact binomial test, p < 0.001). Taken together, these results indicate that the observed increase in activity 
in R6/2 mice affects a large number of cells in the network and can at least in part be attributed to more silent cells 
changing into the intermediately active category, as well as more cells staying active between the imaging sessions.
Increased synchrony in presymptomatic HD mice. As calcium imaging allows simultaneous observation 
of activity in hundreds of cells, we next asked whether neuronal synchrony is altered in the cortical network of HD 
mice. We observed an increase in correlated activity in R6/2 animals compared to WT littermates (Fig. 3a). Analysis 
of the Pearson’s correlation coefficient (r) for neuronal pairs revealed a small, yet highly significant increase in pair-
wise correlations in R6/2 mice at all imaging time points (WT, 88580 cell pairs at 6.5 weeks, 114020 cell pairs at 7.5 
weeks, 111645 cell pairs at 8.5 weeks, 91655 cell pairs at 9.5 weeks, from 6 mice; R6/2, 143716 cell pairs at 6.5 weeks, 
164325 cell pairs at 7.5 weeks, 211011 cell pairs at 8.5 weeks, 222328 cell pairs at 9.5 weeks, from 5 mice; Wilcoxon 
rank-sum test, WT vs. R6/2, p < 0.001 for all time points; Fig. 3b,c). To exclude the possibility that higher pairwise 
correlation in HD mice was due solely to the higher frequency of calcium transients in these animals (see Fig. 2b), 
we also analyzed correlation of shuffled data. For both genotypes, the correlation coefficient of the actual data was 
clearly higher than that of the shuffled dataset (Wilcoxon rank-sum test, WT vs. WT shuffled, p < 0.001 for all time 
points; R6/2 vs. R6/2 shuffled, p < 0.001 for all time points; Fig. 3c). These data point to a higher degree of synchrony 
in the cortical network of presymptomatic R6/2 mice compared to WT animals.
Downregulation of synaptic proteins in R6/2 cortex prior to motor impairments. To gain insight 
into the potential molecular mechanisms underlying the dysregulated activity in the cortex, we took advantage 
of the spatiotemporally resolved mass spectrometry (MS)-based proteomic dataset from R6/2 mice and WT 
littermates that we obtained previously, including changes in the soluble proteome and composition of insoluble 
mHTT inclusion bodies36. For the present study, we focused on cortical samples from 5-week-old (early presymp-
tomatic) and 8-week-old animals (around the age of observed changes in neuronal activity). Principal component 
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analysis (PCA) revealed a clear separation of soluble cortical samples of 8-week-old R6/2 mice from the samples 
of 5-week-old R6/2 and all WT animals (Fig. 4a). We then asked which proteins accounted for this separation. 
Interestingly, the largest functional group among the main PCA drivers that were downregulated in 8-week-old 
R6/2 mice were synapse-related proteins (28%, 7 out of 25 proteins; the fraction of synapse-related proteins in 
the total proteome was 8%, 651 out of 8455 proteins) (Fig. 4b,c, Supplementary Table S1). In contrast, no synaptic 
proteins were found among the main PCA drivers upregulated in R6/2 mice (0 out of 25; Fig. 4b).
While there were no major differences between the soluble cortical proteome of R6/2 and WT mice at 5 weeks, 
we observed marked changes in the R6/2 cortex at 8 weeks of age (Fig. 4d and Supplementary Table S2), consistent 
with the data from other brain regions36. Moreover, there was a pronounced decrease in synaptic protein levels 
(Fig. 4d,e). Importantly, the fraction of downregulated synaptic proteins (10.3%, 67 out of 651 proteins) was signif-
icantly higher than the upregulated fraction (4.0%, 26 out of 651 proteins) (Fisher’s exact test, p < 0.001; Fig. 4e and 
Supplementary Table S2), while the fractions of proteins that were down- or upregulated in the whole proteome 
were not significantly different (4.5% downregulated, 382 out of 8456 proteins; 4.4% upregulated, 375 out of 8456 
proteins, Fisher’s exact test, p = 0.824; Fig. 4e and Supplementary Table S2). This finding points towards a specific 
loss of synaptic proteins in HD mice that is not merely due to the general remodeling of the whole proteome. Among 
the downregulated proteins, we found both excitatory and inhibitory synaptic markers, along with proteins com-
mon to both types of synapses (Fig. 4d). We next asked if the downregulation of synaptic proteins might be due to 
their sequestration within mHTT inclusions. Out of 66 synaptic proteins reduced in the soluble fraction at 8 weeks, 
30 were detected in the insoluble proteome, which largely consists of mHTT inclusions. Remarkably, none of the 
detected proteins that were reduced in the soluble fraction (synaptic or non-synaptic) were found to be significantly 
altered in the insoluble fraction of R6/2 mice (Supplementary Fig. S2 and Supplementary Table S3). Sequestration 
within mHTT inclusions is therefore likely not a major mechanism of protein decrease at an early stage of HD pro-
gression. This is distinct from the situation in 12-week-old R6/2 brains, where many proteins downregulated in the 
soluble pool are enriched in the insoluble material, indicative of their recruitment to mHTT inclusion bodies36. In 
summary, our proteomic results reveal a broad downregulation of synaptic components already before appearance 
of motor dysfunction.
Figure 3. Increased synchrony in R6/2 mice. (a) Representative raster plots of single-cell activity in a WT (top) 
and R6/2 (bottom) mouse during an imaging session at 6.5 weeks of age. Running episodes are depicted in 
black and stationary periods in white at the bottom of the plots. (b) Correlograms from a WT (top) and R6/2 
(bottom) mouse shown in (a) at 6.5 weeks (left) and 8.5 weeks (right). Only active cells were included in the 
analysis, resulting in the different numbers of ROIs captured in the correlograms at different time points.  
(c) Cumulative distributions of pairwise correlation values (Pearson’s r) for actual (solid lines) and shuffled 
(dashed lines) data at different time points. Pairwise correlation analysis was performed on entire traces.
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Loss of inhibitory synapses on pCs. Lower levels of synaptic proteins in the R6/2 mice might reflect a loss of 
synapses. A decrease in excitatory synapses in the R6/2 cortex at an advanced disease stage has been reported previ-
ously24. However, it has remained unclear whether inhibitory contacts are also affected and whether synapse num-
bers are already reduced before motor symptoms develop. We therefore performed immunostainings for excitatory 
and inhibitory pre- and postsynaptic markers in L2/3 of the M1 cortex of 8-week-old animals and quantified densi-
ties of opposing VGlut1/2; PSD-95 puncta as putative excitatory synapses and opposing VGAT; Gephyrin puncta as 
putative inhibitory synapses (Supplementary Fig. S2). These experiments did not reveal significant changes in total 
excitatory or inhibitory synapse densities at 8 weeks (3 FOVs per mouse from 5 WT and 4 R6/2 mice; Student’s t-test; 
excitatory synapses, p = 0.8279; inhibitory synapses, p = 0.6773; Supplementary Fig. S2).
We next focused on a specific subpopulation of inhibitory synapses, parvalbumin (PV)-positive terminals on 
PCs, as PV+ GABAergic inputs are known to provide the strongest source of inhibition onto PCs37,38. The area of 
PV+ puncta surrounding NeuN-labeled PC cell bodies in L2/3 of the M1 cortex of R6/2 mice was unchanged at 
5 weeks of age, but became significantly reduced at 8 weeks, and further decreased at 12 weeks (WT, 74 PCs from 
5 mice, 63 PCs from 5 mice, and 45 PCs from 3 mice for 5, 8 and 12 weeks of age, respectively; R6/2, 74 PCs from 
5 mice, 58 PCs from 4 mice and 45 PCs from 3 mice for 5, 8 and 12 weeks of age, respectively; Student’s t-test, 5 
Figure 4. Downregulation of synaptic proteins in R6/2 cortex. (a) PCA projections of soluble cortical 
samples from 5- and 8-week-old R6/2 mice and WT littermates. (b) Main PCA drivers of the separation that 
are downregulated (yellow frame) and upregulated (green frame) in 8-week-old R6/2 mice. Synapse-related 
proteins are highlighted in black. Main drivers were defined as the top 25 proteins accounting for the separation 
of samples in the PCA. (c) Functional groups of the main PCA drivers downregulated in 8-week-old R6/2 mice 
(indicated by the yellow frame in b). See also Supplementary Table S1. (d) Volcano plot showing proteins up- 
or downregulated in the soluble fraction of 8-week-old compared to 5-week-old R6/2 cortex. Proteins above 
the curved q-value cutoff line are statistically significantly changed (q < 5%); Excitatory synaptic proteins are 
highlighted in red, inhibitory in blue, common in black; filled circles indicate significantly changed synaptic 
proteins. (e) Fraction of proteins significantly (q-value < 5%) up- or downregulated in the soluble proteome of 
the R6/2 compared to WT cortex at 8 weeks. ***p < 0.001. See also Supplementary Table S2.
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weeks, p = 0.3131; 8 weeks, p = 0.0257; 12 weeks, p = 0.0047; Fig. 5a,b). Double immunostainig for PV and the 
inhibitory presynaptic protein VGAT revealed a clear colocalization of the two markers around PC cell bodies 
(Fig. S2), indicating that perisomatic PV+ puncta truly represent inhibitory synaptic terminals. To validate these 
histological findings in human disease cases, we performed immunostainings for PV+ terminals in postmortem 
brain tissue of HD patients and age-matched controls (Supplementary Table S4). Consistent with the results 
from R6/2 mice, we observed a marked reduction in the area of PV+ puncta around L2/3 PCs in the primary 
motor cortex (Ctrl, 69 PCs from 3 brains; HD, 75 PCs from 3 brains; Student’s t-test, p < 0.001; Fig. 5c,d). To find 
out whether the reduction in PV+ inputs is due to cell loss in this interneuron population, we also analyzed the 
density of PV+ cell bodies. As L2/3 PCs were shown to receive both local as well as translaminar PV+ inputs39, 
PV+ cell density was quantified throughout the cortex. We did not observe significant changes in PV+ cell den-
sity in 8-week-old or 12-week-old R6/2 mice (8 weeks, 5 WT and 4 R6/2 mice; 12 weeks, 3 WT and 3 R6/2 mice; 
Student’s t-test, 8 weeks, p = 0.3997; 12 weeks, p = 0.2986; Fig. 5e,f), or in HD patients (3 controls and 3 HD 
cases; Student’s t-test, p = 0.3490; Fig. 5g,h), suggesting that the decrease in PV+ teminals is not a result of lower 
PV+ cell numbers. In summary, loss of GABAergic inputs onto PCs occurs both in R6/2 mice and in human HD 
cases, suggesting that weakened inhibition might at least partially explain dysregulated cortical activity in HD.
Discussion
Using chronic in vivo imaging in awake animals, we demonstrate defects of cortical network function in HD 
mice, with an overall increase in activity, higher fraction of active cells, and increased pairwise correlations. 
Our results extend previous observations of dysregulated neuronal activity and cortical hyperexcitability in HD 
rodent models detected by electrophysiology in slices and in vivo8,25,40. Moreover, a recent two-photon imaging 
study, conducted in the visual cortex of anesthetized Hdh150 knock-in mice, also described an increase in activ-
ity and synchronicity in premanifest HD animals41. While our findings are in agreement with these studies, our 
chronic imaging approach enabled us for the first time to observe cortical network changes in awake animals at a 
Figure 5. Reduction in inhibitory synaptic terminals on PCs in R6/2 mice and HD patients. (a,b) 
Representative images (a) and quantification (b) of PV+ synaptic terminals (red) on NeuN-labeled PC cell 
bodies (green) in L2/3 of M1 cortex from R6/2 mice and WT controls. (c,d) Representative images (c) and 
quantification (d) of PV+ synaptic terminals (red) on Neurotrace-labeled PC cell bodies (green) in L2/3 of M1 
cortex from HD autopsy cases and controls. (e) Representative images of PV+ cells in M1 cortex of 8-week-
old WT and R6/2 mice. Nuclei were counterstained with DAPI. Dashed lines denote borders between cortical 
layers. (f) Quantification of PV+ cell densities in M1 cortex of WT and R6/2 mice. (g) Representative images 
of PV+ cells in M1 cortex of HD cases and controls. Neuronal cell bodies are labeled with Neurotrace. Dashed 
lines denote borders between cortical layers. Insets show a higher magnification of the areas marked by dashed 
boxes. (h) Quantification of PV+ cell densities in M1 cortex of HD cases and controls. *p < 0.05; **p < 0.01; 
***p < 0.001.
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single-cell resolution, and to pinpoint the exact timing of these changes. Remarkably, most of the alterations we 
observed occurred rather abruptly at the age of 8.5 weeks, before the appearance of motor defects. These impair-
ments of cortical activity might therefore critically contribute to the onset of motor dysfunction. In addition, 
increased synchrony was already detected at 6.5 weeks, the earliest age examined, suggesting that subtle changes 
in cortical network function already happen at an early presymptomatic stage.
The R6/2 transgenic fragment model used in this study was chosen because of its well-characterized pheno-
type and rapid disease progression. Furthermore, it shows extensive similarities with more recent models express-
ing full-length mHTT in terms of cortical pathology and electrophysiology25,42. Nevertheless, it will be important 
to validate our findings in a full-length HD model in the future.
Dysregulation of cortical activity observed in HD mice might in turn lead to profound changes of neuronal 
function in the striatum. Early in HD progression, hyperactivity of striatal neurons was described in R6/2 mice43, 
and elevated glutamate levels were detected in the striatum of HD patients44. These alterations could in part be 
due to increased activation of the striatum by cortical inputs. Remarkably, removal of cortical afferents resulted in 
amelioration of HD phenotypes in R6/2 mice45, and expression of mHTT in cortical neurons was necessary and 
sufficient to cause functional impairments of the striatal compartment in a corticostriatal network reconstructed 
in vitro46. It remains to be tested whether restoration of normal cortical activity levels, e.g. with the help of che-
mogenetic tools, would also be sufficient to rescue or delay HD symptoms. It should be noted that the majority of 
corticostriatal afferents originate from L5 PCs, however, L2/3 cells imaged here provide the main source of input 
to L5 PCs47 and are therefore likely to critically influence corticostriatal communication. In future experiments it 
will be important to also assess the function of L5 neurons directly.
The excessive activity observed in R6/2 mice was broadly distributed across the network, with a majority 
of cells showing a moderate increase in calcium transient frequency, suggesting that HD-related neurodegen-
erative processes have a global impact on the cortical network. Interestingly, another in vivo imaging study 
conducted in anesthetized Hdh150 mice revealed an increase in the fraction of hyperactive cells in the visual 
cortex at an early, “very far from disease onset” stage41. This is in contrast to our finding of a mild and broadly 
distributed increase in activity without the appearance of hyperactive neurons. This discrepancy might be due 
to the different disease stages, cortical areas and mouse models used, as well as methodological differences 
between the studies, such as the usage of different calcium indicators and imaging in awake vs. anesthetized 
animals. To reconcile these observations, it would be necessary to perform chronic imaging in HD mice dur-
ing a broader time period from very early presymptomatic to symptomatic disease stages. We furthermore 
detected altered activity dynamics at single-cell level, with more neurons remaining active between imaging 
sessions, as well as more cells changing from silent to intermediately active. Highly dynamic activity patterns 
that are characteristic of the motor cortex are believed to be important for motor learning48. Of note, motor 
learning impairments have been described in HD mouse models49,50 as well as HD patients51. In future studies, 
it will be interesting to investigate the possible role of cortical activity in these behavioral changes by combin-
ing in vivo microscopy with a learning task.
What might be the molecular link between expression of mHTT and defects of neuronal communication in 
the cortex? Our proteomic analyses demonstrated a major downregulation of synaptic proteins in R6/2 mice. 
In addition to confirming reductions in certain synaptic proteins shown previously in HD mice and human 
brain samples at advanced disease stages52–55, our dataset reveals a broad downregulation of multiple synaptic 
components that occurs already before any motor abnormalities can be detected. Moreover, while the loss of 
general and excitatory synaptic markers in HD cortex is well documented24,52,55, we find that inhibitory synaptic 
proteins are singificantly affected as well. This is in agreement with recent transcriptomic data showing downreg-
ulation of genes involved in GABA metabolism and signaling in iPSC-derived neural cultures from HD patients56. 
Surprisingly, the majority of synaptic proteins that were downregulated in the soluble fraction were not altered in 
the insoluble material at 8 weeks of age, arguing against sequestration as a major mechanism of synaptic protein 
depletion at this disease stage23,36. Synaptic defects in HD might result to some extent from loss of native HTT 
function, as HTT is required for normal synapse development in the cortex57. Another likely mechanism of syn-
aptic protein reduction might be transcriptional dysregulation, as genes related to synaptic signaling were among 
the most prominent dysregulated gene clusters in transcriptomic analyses of HD mice and human iPSC-derived 
neural cultures56,58,59.
In addition to the reduction in synaptic proteins detected by mass spectrometry, our histological analyses 
revealed a reduction in PV+ inhibitory synaptic contacts on PCs in R6/2 mice in the absence of PV+ cell loss, 
which was confirmed in human HD autopsy cases. It should be kept in mind that postmortem HD brain tissue 
represents an advanced disease stage. Nevertheless, the similarity of histological findings in R6/2 mice and HD 
patients illustrates the relevance of our results for the human disease. While the exact causal link between synap-
tic defects and the observed cortical network disturbances remains to be investigated, our findings suggest that 
abnormalities of cortical function in HD could at least in part be explained by a disturbed excitation/inhibition 
balance. This hypothesis is also in agreement with the increased synchrony in the cortex of HD mice observed 
by us and others41, as correlated firing in cortical circuits is controlled by inhibitory interneurons60. Reduced 
frequency of inhibitory postsynaptic currents has been described in L2/3 PCs in the motor and somatosensory 
cortex in several HD mouse models at a symptomatic stage19,25,26. Remarkably, human studies with the use of 
transcranial magnetic stimulation revealed abnormal cortical excitability due to dysfunctional inhibition in pre-
symptomatic and early-stage HD patients16,61, emphasizing the translational value of our findings. Impairments 
in the function of inhibitory neurons have also been suggested to underlie neural circuit defects in mouse models 
of Alzheimer’s disease62,63 and may therefore represent a common phenomenon in various neurodegenerative 
disorders. Taken together, our chronic single-cell resolution imaging approach, in combination with quantitative 
proteomic analyses and histological experiments, points towards disturbed cortical excitation/inhibition balance 
at the presymptomatic stage as a key mechanism in HD pathogenesis.
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Methods
transgenic mice. R6/2 mice28 transgenic for the 5′ end of the human huntingtin gene were maintained by 
crossing R6/2 males to F1 C57Bl6/CBA females. Animals were kept in a specific pathogen-free animal facil-
ity with free access to food and water. The presence of the transgene was verified by PCR with the following 
primers: forward, 5′-CCGCTCAGGTTCTGCTTTTA-3′, reverse, 5′-TGGAAGGACTTGAGGGACTC-3′. 
CAG repeat length was determined by Laragen. Female R6/2 mice and WT littermates were used in all 
experiments. After surgery, mice were kept in inverted 14–10 h light-dark cycle. All animal experiments 
were approved by the Government of Upper Bavaria (animal protocols 55.2-1-54-2532-168-2014, 55.2-1-
54-2532-19-2015), and all the methods were performed in accordance with the relevant guidelines and 
regulations.
Behavioral tests. Rotarod. Rotarod test was performed on a Rota-Rod NG (Ugo Basile). Mice were first 
trained on two consecutive days for 300 s at 5 rpm, and then tested with acceleration from 5 to 40 rpm over a 300 s 
period. Latency to fall was recorded on three trials separated by 15 min resting periods, and the average value was 
taken for analysis.
Open field. Locomotor activity in the open field was assessed one hour after the beginning of the dark cycle. 
Mice were placed into a custom-made 40 × 40 cm arena, and total distance traveled was recorded for 10 min. The 
floor of the chamber was washed between the trials to minimize any olfactory cues that could affect exploratory 
behavior.
Virus injection and cranial window surgery. For in vivo calcium imaging, an adeno-associated virus 
(AAV1/2) containing the genetically encoded calcium indicator GCaMP6s64 and the structural marker mRuby265 
under the control of the human synapsin-1 promoter was used to label cortical neurons34. Intracerebral injections 
of AAV and cranial window implantation were performed within the same surgery in 3.5-week-old mice deeply 
anesthetized with an intraperitoneal (i.p.) injection of ketamine/xylazine (130 and 10 mg kg−1 body weight, 
respectively). The analgesic carprofen (5 mg  kg−1 body weight, subcutaneously) and the anti-inflammatory drug 
dexamethasone (10 mg kg−1, i.p.) were administered shortly before surgery. To increase viral uptake and spread, 
mannitol (20% solution; 30 ml kg−1 body weight, i.p.) was applied 20 min prior to virus injection66. During sur-
gery, the virus (titer: ~1012 infecting units per ml) was injected into L2/3 of M1 cortex (3 injection sites with 
stepwise 300 nl injections at 150, 200 and 250 µm depth). A cranial window was implanted over the right cortical 
hemisphere as previously described67. Briefly, a circular piece of skull (4 mm in diameter) was removed over 
the fore- and hindlimb area of M1 (position: 1.3 mm lateral and 1.0 mm anterior to bregma) using a dental drill 
(Foredom). A round coverslip (VWR; d = 4 mm) was glued to the skull using histoacryl glue (B.Braun) and dental 
acrylic cement (Kerr Vertise Flow). After surgery, mice received a subcutaneous injection of the antibiotic cefo-
taxime (60 mg kg−1) and were placed in a warm environment for recovery. After 10 days, a small custom-made 
metal bar (1 cm × 3 cm; 0.06 g) with a round opening was glued onto the coverslip with dental acrylic cement to 
allow for stable head fixation under the objective and repeated repositioning of mice during subsequent imaging 
sessions. Imaging began after a 21-day resting period after surgery.
Handling and ball training. At the age of 5 weeks, mice were handled on 5 consecutive days for 10 min 
until they were familiarized with the trainer and routinely ran from hand to hand. In the subsequent ball train-
ing mice got adjusted to the experimental setup and head fixation. Ball training sessions that were repeated on 
3 consecutive days were set in the dark with an IR light source and lasted for 30 min. Mice were head-fixed by 
the metal bar to a custom-made holder and placed onto a styrofoam ball (d = 20 cm) that floated on pressur-
ized air35. After the third session, mice had adjusted to the head fixation and showed alternating running and 
resting behavior.
two-photon calcium imaging in behaving mice. During the experiment, the same conditions as dur-
ing ball training were applied. Mouse behavior was tracked at 15 Hz with an IR-sensitive video camera (USB 2.0, 
1/3″CMOS, 744 × 480 pixel; 8 mm M0814MP2 1.4–16 C, 2/3″, megapixel c-mount objective; TIS) and custom 
software (Input Controller, TIS). In addition, to track ball motion, a computer gaming mouse (G500S, Logitech) 
was positioned along the ball axis, controlled by a raspberry pi3 and custom written scripts using PuTTY to 
count ball rotation events (1000 counts/s). To synchronize in vivo two-photon imaging, behavioral video record-
ing and ball speed measurements, a 900 s lasting TTL pulse (5 V) was sent to relevant hardware using Matlab 
(Mathworks). In vivo calcium imaging was performed with an upright multiphoton microscope (Bergamo II, 
Thorlabs) equipped with a Ti:Sapphire laser with dual beam (InSight DeepSee, Spectra Physics), a 8 kHz galvo/
resonant scanner and a 16x, 0.8 NA water immersion objective (Nikon). The laser intensities were modulated with 
Pockels cells (Conoptics). The following wavelengths and emission filters were used to simultaneously image the 
two fluorophores: 920 nm/525 ± 25 nm (GCaMP6s) and 1040 nm/607 ± 35 nm (mRuby2). ThorImage 2.4 soft-
ware (Thorlabs) was used for microscope control and image acquisition. To measure neuronal activity, time series 
images of selected positions/FOVs with bright expression of the calcium indicator were acquired at 10 Hz for a 
total duration of 900 s. For each mouse, two FOVs were recorded per imaging time point at the depth of 150–350 
μm. For each FOV, an image of the blood vessel map was acquired under epifluorescence to ensure return to 
the same position in serial experiments. In addition, the information about XYZ-coordinates provided by the 
microscope stage was documented for each image position. The structural marker mRuby2 was used to precisely 
adjust the FOV in the z-plane. After imaging, the animal was returned back to its housing cage for rest. At the 
last imaging time point, in some of the mice the same FOVs were additionally imaged for 300 s during isoflurane 
(1.5%) anesthesia.
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time series image processing and data analysis. Image analysis was performed with ImageJ (NIH) 
and Matlab software using custom written procedures. First, full frame images were registered and motion 
corrected in ImageJ using the moco plugin68. Next, regions of interest (ROIs) were drawn manually around 
individual somata based on both maximum and mean intensity projections of all frames. For neighboring 
cells with direct contact, pixels containing signals from both cells were excluded from the selection. For each 
imaging time point, the ROIs were visually inspected in the GCaMP and mRuby channel to ensure that the 
same cells were analyzed throughout the imaging period. The fluorescence intensity of all pixels inside each 
ROI was averaged and mean values were imported into Matlab for further processing as described previously69. 
To account for neuropil contamination, the following correction method was applied: the initial ROI was 
fitted with an ellipse and this ellipse was stretched by 6 pixels. All pixels of the initial ROI, as well as those of 
neighboring ROIs were excluded from the resulting larger ellipse. Next, the corrected ROI signal was com-
puted as follows: FROI_comp = FROI − 0.7 × (Fneuropil − median (Fneuropil)), with FROI_comp representing the neuropil 
compensated fluorescence of the ROI, FROI referring to the fluorescence signal of the initial ROI selection and 
Fneuropil to the signal stemming from the neuropil69. To estimate the baseline level (F0), each fluorescence trace 
was divided by the median of all values smaller than the 70th percentile of the entire trace, which reflects the 
baseline well as judged by visual inspection. Cells were classified as active in a particular experiment if they 
crossed a threshold of baseline +3 × standard deviation (SD) of the ∆F/F trace at least once for a minimum 
of 10 consecutive frames (1 s). The degree of synchrony between neurons was computed based on entire bina-
rized calcium traces. To this end, the ∆F/F traces of active cells were low pass filtered at 0.3 Hz, smoothed 
across 4 frames and subsequently thresholded at 2 × SD of the noise band of the original trace. The Pearson’s 
correlation coefficient (r) for each ROI pair within a FOV was then computed. Shuffled data was generated by 
circularly shifting the calcium trace of each ROI by a random value.
Video sequences acquired for behavioral tracking were analyzed in EthoVision (Noldus), using the activity 
analysis tool. Briefly, a ROI was drawn manually around the forepaws. Changes in pixels induced by forepaw 
movement were registered as activity change and plotted over time by determined algorithms. For direct compar-
ison of video and imaging data at equal frame numbers, the 15 Hz videos were reduced to 10 Hz using the signal.
resample function from Scipy and imported into Matlab for further analysis.
Ms data analysis. All data was obtained from the proteomic dataset published by Hosp et al.36. Log2-transformed 
label free quantification (LFQ) protein intensity values were used for quantitative analysis. Bioinformatic analyses 
were conducted with the Perseus software package70 using version 1.6.1.3 for Volcano plots and 1.5.2.11 for all other 
analyses. The cutoff for statistical significance was a q-value of 5% using the permutation-based decoy model for false 
discovery rate (FDR) control in multiple testing within the Perseus package. The s0-parameter weighing the effect size 
of protein changes in Volcano plot q-value calculation was kept at the default value of 0.1. Annotations were based 
on GOCC, GOBP, GOMF, CORUM, uniprot protein family, uniprot interaction partner, Pfam domains and KEGG 
pathway annotations with the exception of the main PCA drivers, which were complemented by manual annotations 
based on literature searches.
Immunofluorescent staining and confocal microscopy. Mice were transcardially perfused with 
phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA) in PBS. Brains were dissected out, 
post-fixed in 4% PFA at 4 °C for 48 h, and coronal brain sections (70 μm) were cut on a microtome (VT 1000 S, 
Leica). Free-floating sections were permeabilized in 0.5% TritonX-100 in PBS for 30 min and blocked in 5% 
normal donkey serum, 0.2% bovine serum albumin (BSA), 0.2% glycine, 0.2% lysine, 0.02% sodium azide in 
PBS for 2 h at room temperature, followed by overnight exposure to primary antibodies in 0.3% TritonX-100, 
2% BSA, 0.02% sodium azide in PBS. The following primary antibodies were used: rabbit anti-PV (Abcam), 
mouse anti-NeuN (Millipore), guinea-pig anti-VGlut1 (Millipore), guinea-pig anti-vGlut2 (Millipore), mouse 
anti-PSD-95 (Sigma), mouse anti-Gephyrin (Synaptic Systems), rabbit anti-VGAT (Synaptic Systems), and mouse 
anti-VGAT (Synaptic Systems). After several washes with PBS, sections were incubated in corresponding Alexa 
secondary antibodies (Invitrogen) diluted 1:300 for 2 h followed by 10 min DAPI (Sigma) staining, several PBS 
washes and mounting with fluorescent mounting medium (DAKO). Fluorescence images were acquired with a 
Leica TCS SP8 confocal microscope using a 63x, 1.40 NA oil immersion objective (Leica). Image analysis was 
performed blindly. Cell counts were conducted on DAPI images using a custom-written macro in Cell Profiler. 
For analysis of synapse densities, images of pre- and postsynaptic stainings were converted into binary masks in 
ImageJ. Puncta of 2 pixels or less were excluded from further analysis. The coordinates of the remaining puncta 
were extracted using the “analyze particles” function. The distance of every presynaptic particle to every postsyn-
aptic particle was then calculated using the Pythagorean equation and matrix calculations in R. A distance of 1 μm 
or less was counted as a synapse. For PV puncta quantification, the PC circumference was traced manually 
and measured with ImageJ. The area of the cell body and the surrounding PV staining were extracted and the 
PV-positive pixels counted using a custom written macro. The area of PV terminals around the cell body was 
normalized to the cell body perimeter.
patient material. 5 µm paraffin sections from the primary motor cortex of 3 HD autopsy cases and 3 
age-matched controls were obtained from Neurobiobank Munich, Ludwig-Maximilians University Munich. 
Informed consent was available for all cases. The experiments were approved by the ethics committee of 
Ludwig-Maximilians University Munich, and performed in accordance with the relevant guidelines and reg-
ulations. All HD cases were symptomatic. Demographic information is provided in Supplementary Table S4. 
Sections were deparaffinized in Xylene twice for 5 min, hydrated in a decreasing ethanol concentration series, and 
transferred to warm tap water for 5 min. Antigen retrieval was conducted in boiling Tris-EDTA buffer (10 mM 
Tris, 1 mM EDTA, 0.05% Tween 20, pH 9.0) for 15 min. Slides were then transferred to tap water and blocked 
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with BLOXALL Blocking Solution (Vector Laboratories) for 10 min and subsequently with 2.5% horse serum for 
30 min. The following primary antibodies were used: rabbit anti-PV, 1:250 (Abcam) and mouse anti-CamK2α, 
1:250 (Abcam). After several washes with PBS, sections were incubated in corresponding Alexa secondary anti-
bodies (Invitrogen) diluted 1:300, and Neurotrace, 1:500 (Life technologies) for 2 h followed by 10 min DAPI 
(Sigma) staining, several PBS washes and mounting with fluorescent mounting medium (DAKO). Fluorescence 
images were acquired with a Leica TCS SP8 confocal microscope using a 63x, 1.40 NA oil immersion objective 
(Leica). PCs in L2/3 were identified by their triangular shape, the presence of a nucleolus seen with Neurotrace, 
and/or through Camk2α-positive staining. Image analysis was performed with ImageJ and R. For PV+ puncta 
quantification, the circumference of the pyramidal neuron was traced manually, dilated by 1.5 µm and measured 
with ImageJ. The area of the cell body and the surrounding PV staining was extracted and the PV-positive pixels 
counted using a custom-written macro. The area of PV+ terminals around the cell body was normalized to the 
cell body perimeter.
statistical analysis. Data were analyzed in a blinded manner. Data are expressed as mean ± SEM unless 
indicated otherwise, with p < 0.05 defining differences as statistically significant (*p < 0.05; **p < 0.01; 
***p < 0.001; n.s. - not significant).
Data Availability
The data generated during this study are available from the corresponding authors upon reasonable request.
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